Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.

There is no fulltext present in this item.

Title:	Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition.
Author(s):	Oosterhoff, D.; Lougheed, S.; Ven, R. Van de; Lindenberg, J.J.; Cruijsen, H. van; Hiddingh, L.; Kroon, J.; Eertwegh, A.J. van den; Hangalapura, B.; Scheper, R.J.; Gruijl, T.D. de
Publication year:	2012
Source:	Oncoimmunology, vol. 2012, iss. Aug 1; 1(5), (2012), pp. 649-658
ISSN:	2162-4011
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/110072
Display more details
Subject:	NCMLS 2: Immune Regulation ONCOL 3: Translational research Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Laboratory of Hematology
Journal title:	Oncoimmunology
Volume:	vol. 2012
Issue:	iss. Aug 1; 1(5)
Page start:	p. 649
Page end:	p. 658